Navigation Links
GADA Points to Safety of FDA Approved Generics in Wake of Wellington Polo Horse Deaths from Compounded Drugs
Date:5/6/2009

WASHINGTON, May 6 /PRNewswire/ -- The Generic Animal Drug Alliance (GADA), an independent professional trade organization representing generic animal health industry interests, says that the recent tragic deaths of 21 horses in Wellington, Florida illustrates the potential safety issues surrounding compounded drugs and reinforces the need for, and value of, Food and Drug Administration (FDA) approved animal generic drugs.

The polo horse deaths were reportedly caused by improperly compounded drugs. Compounded drugs are customized medications prepared by a pharmacist under prescription by a veterinarian. Considered a last resort, compounded drugs should be used only when no FDA-approved animal or human drug is available to treat the animal. Unlike generic drugs, compounded drugs are not FDA-approved and do not follow current good manufacturing practice (cGMP) requirements.

GADA has been working to help veterinarians understand the difference between compounded drugs and generic drugs. Generic drugs, widely used and trusted by veterinarians, are FDA-approved bio-equivalent versions of branded medicines, manufactured under strict regulatory guidelines. Generic drugs, as with other FDA-approved drugs, undergo rigorous testing to meet quality standards. Stephanie Batliner, GADA Chairperson, says that veterinarians face a variety of prescribing options and must be aware of the safety issues. "While generic drugs meet safety standards ensured by FDA-approval, compounded drugs have inherent risks associated with uncontrolled, extemporaneous preparation," says Batliner. GADA provides further information on their website, as well as a link to the brochure "Veterinary Compounding" co-authored by the American Veterinary Medical Association (AVMA), the Animal Health Institute (AHI), and the American Veterinary Distributors Association (AVDA), www.gadaonline.org.

About Generic Animal Drug Alliance

The Generic Animal Drug Alliance (GADA) is an independent professional trade organization that represents the interests of generic animal health companies before Federal regulatory agencies and Congress. Member companies are focused on the development, approval and marketing of high quality generic drugs for animals and pets--making the cost of care for all animals affordable for ranchers, farmers and pet owners.


'/>"/>
SOURCE The Generic Animal Drug Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Candies Foundation Appoints Bristol Palin As Teen Ambassador
2. WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance
3. Shamir Optical Industry Ltd. Appoints Amos Netzer as New Chief Executive Officer
4. Protein Sciences Corporation Appoints New Board of Directors
5. China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member
6. Mother-daughter breast density study points way to earlier cancer risk assessment
7. PDL BioPharma Appoints Karen J. Wilson as Vice President, Finance and Principal Accounting Officer
8. Craneware Appoints New Non-Executive Director
9. BMP Sunstone Appoints Les R. Baledge to Board of Directors
10. ATS Medical Appoints New Vice President of Marketing
11. InfuSystem Appoints Bryan Russo as Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... San Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... restoration treatment, is proud to announce a new blog post about women’s hair loss. ... women suffer from hair loss as they age. Menopause or genetics can be two ...
(Date:3/28/2017)... ... 2017 , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. ... that his parents and teachers had asked of him that he had neglected to do, ... defy the Almighty Creator. There were some who would have felt themselves to be special ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. ... smile makeovers without requiring a referral. Trimble Dental offers a variety of ... dentistry and dental implants. Whether patients have discolored, crooked or missing teeth in ...
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... 3.0 was transitioned to the OSEHRA popHealth Community in 2014. It ... Work Group and the Developer Open Source Project Group. OSEHRA Organizational Member Zato ...
(Date:3/27/2017)... ... March 27, 2017 , ... Adding to its ... Journal of Medicine and NEJM Journal Watch, announces the release of NEJM ... by a panel of pediatricians from leading medical centers. The content was then ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 On Friday, benchmark ... Composite closed the trading session up 0.19%; the Dow ... 500 was down 0.08%. US markets made broad based ... day in green. Pre-market today, Stock-Callers.com reviews these four ... (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. ...
(Date:3/27/2017)... 2017 Cota Healthcare, the leading ... medicine, today announced the signing of a ... to help improve clinical and cost outcomes ... part of this agreement, which expands significantly ... January 2016, teams from across Novartis Pharmaceuticals ...
(Date:3/24/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 ... of cell therapy manufacturing and focuses both on contract manufacturers ... are anticipated to emerge as viable alternatives to conventional treatment ...
Breaking Medicine Technology: